CEFALEXIN

DRUG4 trials

Sponsors

University Medical Center Utrecht, Consorci Mar Parc De Salut De Barcelona, Friedrich-Schiller-Universitaet Jena, University Of Cologne

Conditions

Infectious endocarditis caused by Gram-positive cocci (staphylococciStaphylococcus aureus bacteremiabone and joint infectionsenterococcirecurrent urine infectionsstreptococci)

Phase 3

Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci

Not yet recruitingCTIS2026-526149-91-00

Friedrich-Schiller-Universitaet Jenaenterococci, Infectious endocarditis caused by Gram-positive cocci (staphylococci, streptococci)

Target: 166Updated: 2026-06-30

Phase 4

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

RecruitingCTIS2023-503582-35-00

University Medical Center UtrechtStaphylococcus aureus bacteremia

Start: 2023-10-26Target: 2348Updated: 2026-01-08

Randomized, multicenter, open-label clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis to antibiotics in the management of recurrent urinary tract infections in women

Not yet recruitingCTIS2025-523922-42-00

Consorci Mar Parc De Salut De Barcelonarecurrent urine infections

Target: 204Updated: 2026-03-25

Early switch to oral antibiotic therapy in vertebral osteomyelitis: a multicentre, open-label, randomised, active control, parallel group, non-inferiority trial (sWITCH-VO)

Not yet recruitingCTIS2026-526270-17-00

University Of Colognebone and joint infections

Target: 280Updated: 2026-07-09